From 1986 to 2020 they operated as Robarts Clinical Trials and built a strong foundation in the medical research community. In 2020, they became Alimentiv but retained their commitment to clinical trials, medical imaging, and precision medicine for GI-related ailments.
Their Mission: Transform human health by building enduring businesses that prioritize research and the best interests of their employees.
Their Vision: Foster innovation in healthcare by investing profits back into research and development, identifying novel solutions to unmet needs, engaging talented people, and providing them with the resources to succeed.
Their Culture and Values: Their culture and values truly separate them from others. They define the attitudes and behaviours that help them achieve their Mission and Vision.
They Are Global
They are a culturally diverse organization with a presence in two continents. Today, they have offices in Canada (HQ), Toronto, Amsterdam and San Diego.
They Are Collaborators
They work with pharmaceutical and biotechnology companies, key opinion leaders and the investigator community to advance the development of effective treatments. From concept to completion, they provide tailored and innovative recommendations for the design and implementation of research.
They Are Pioneers
They consistently develop new ways to improve clinical trial outcomes and accelerate drug development timelines. They are the first to bring solutions for central imaging of endoscopy and histopathology to the market, and they recently built a translational science network that can accelerate and enhance early drug development.
They are recognized experts in inflammatory bowel disease and clinical trial design
They are known as leaders in outcomes development, cluster randomization trials and centralized imaging solutions. Their experience in R&D and clinical research forms the basis for their integrated solutions to complex operational needs and regulatory standards.
For 30 years, Robarts Clinical Trials grew from a unit within the Robarts Research Institute at Western University to a global organization with more than 600 employees.
In 2020, they transitioned ownership of the organization to an independent Health Trust with a mission to Transform Human Health and a guiding principle of using profits from their operations to build enduring businesses that prioritize research and the best interest of their employees.
In line with their continued evolution, they decided to rebrand the company to Alimentiv.
Alimentiv, derived from Alimentary, connects with their vision to be a leading GI CRO that accelerates drug discovery. Its meaning, to nourish and provide sustenance, represents their values of building enduring businesses that prioritize research and people.
With a vision to transform human health through academic and private partnerships, the organization has reinvested its profits into research that aligns with a purpose shareed by their partners - to accelerate drug discovery.